Logo

American Heart Association

  26
  0


Final ID: MP1727

Contemporary Management and Outcomes of Newly Diagnosed Chronic Limb Threatening Ischemia in the Veterans Affairs Health Care System

Abstract Body (Do not enter title and authors here): Introduction: Chronic limb threatening ischemia (CLTI) is associated with high risks of amputation and mortality. The purpose of this study was to investigate the patterns of management of patients with new onset CLTI in the Veterans Affairs Health Care System.
Methods: We identified patients with new-onset peripheral artery disease (PAD), defined by ankle-brachial index (ABI) <0.9, from 2015-2020 who progressed to CLTI, based on ICD codes, before the year 2024, within a longitudinal registry of PAD among Veterans (Peripheral Artery Disease: Long-term Survival Study – PEARLS). The main exposure was revascularization (surgical or endovascular) within 6 months of CLTI diagnosis. A Cox proportion hazards model examined the association between revascularization and the composite endpoint of death and major amputation, adjusted for demographics, PAD severity, smoking status, and comorbidities.
Results: Among 20,070 patients with newly diagnosed CLTI, 10,247 (51.1%) underwent revascularization (27% surgical, 73% endovascular) within 6 months. Compared to patients who did not undergo revascularization (non-revascularization group), patients in the revascularization group were younger, more likely to be active smokers, and have severe PAD (Table 1). Overall, 76.3% underwent additional diagnostic studies following CLTI diagnosis and 61.4% were referred to a vascular specialist; both rates were higher in the revascularization compared to the non-revascularization group (Table 1). The median time to revascularization was 4 days. At 1 year, patients in the revascularization group had lower rates of major amputation (12.2% vs. 14.6%), mortality (16.0% vs. 21.2%) and higher amputation free survival (74.6% vs. 68.2%) (Figure). Among those with major amputation (3821 [19.0%]), median time to amputation was longer in the revascularization group (207 days vs. 29 days). Based on the adjusted cox proportional hazard model, age >80, diabetes, chronic kidney disease, heart failure and weight loss were associated with higher risk of death or major amputation, whereas revascularization was significantly associated with a lower hazard ratio for the composite endpoint (Table 2).
Conclusion: Among Veterans with new CLTI, more than 75% receive additional diagnostic evaluation, 60% are referred to a vascular specialist, and 1 in 2 undergo revascularization. Although revascularization is associated with improved outcomes, the overall rate of major amputation and mortality remains high.
  • Tsai, Shirling  ( UNIVERSITY TEXAS SOUTHWSTRN MED CTR , Dallas , Texas , United States )
  • Nguyen, Cathy  ( UNIVERSITY TEXAS SOUTHWSTRN MED CTR , Dallas , Texas , United States )
  • Li, Qiang  ( UNIVERSITY TEXAS SOUTHWSTRN MED CTR , Dallas , Texas , United States )
  • Modrall, John  ( UNIVERSITY TX SOUTHWESTERN MED CTR , Dallas , Texas , United States )
  • Banerjee, Subhash  ( Baylor University Medical Center , Dallas , Texas , United States )
  • Beckman, Joshua  ( UT Southwestern , Dallas , Texas , United States )
  • Girotra, Saket  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Author Disclosures:
    Shirling Tsai: DO have relevant financial relationships ; Consultant:AngioSafe, Inc:Active (exists now) | Cathy Nguyen: No Answer | Qiang Li: DO NOT have relevant financial relationships | John Modrall: DO NOT have relevant financial relationships | Subhash Banerjee: DO have relevant financial relationships ; Consultant:AngioSafe:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Esperion:Past (completed) ; Research Funding (PI or named investigator):Philips:Expected (by end of conference) ; Research Funding (PI or named investigator):GE Healthcare:Active (exists now) ; Speaker:Kaneka:Active (exists now) | Joshua Beckman: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Tourmaline:Active (exists now) ; Consultant:Regeneron:Active (exists now) ; Consultant:Novo Nordis:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Minsight:Active (exists now) ; Consultant:Merck:Active (exists now) | Saket Girotra: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Top Clinical and Translational Abstracts in Vascular Medicine

Sunday, 11/09/2025 , 11:50AM - 01:05PM

Moderated Digital Poster Session

More abstracts on this topic:
Acoramidis Effect on All-Cause Mortality in Patients with p.V142I (V122I) Variant ATTR-CM: Findings From the ATTRibute-CM Study

Alexander Kevin, Bhatt Kunal, Judge Daniel, Grodin Justin, Akinboboye Olakunle, Chen Chris, Tamby Jean-francois, Castano Adam, Fox Jonathan, Fontana Marianna, Gillmore Julian, Sarswat Nitasha, Grogan Martha, Solomon Scott, Davis Margot, Cuddy Sarah, Kittleson Michelle, Shah Keyur, Griffin Jan, Ruberg Frederick, Khouri Michel

Advanced Age Increases Susceptibility to Ischemic Myopathy after Murine Hindlimb Ischemia

Kulkarni Deepali, Massie Pierce, Justus Matthew, Mazloumibakhshayesh Milad, Coffman Brittany, Pace Carolyn, Clark Ross

More abstracts from these authors:
Association Between Blood Pressure and Clinical Events in Peripheral Artery Disease with Small Vessel Disease

Nathani Rohit, Girotra Saket, Vaughan Sarrazin Mary, Chan Paul, Gupta Ajay, Kumbhani Dharam, Li Qiang, Nguyen Cathy, De Lemos James, Beckman Joshua

Association Between In-hospital Cardiac Arrest Incidence and Survival in Older Patients

Nathani Rohit, Li Qiang, Nguyen Cathy, Koshy Thomas, Hall Hurst, Mentias Amgad, Chan Paul, Girotra Saket

You have to be authorized to contact abstract author. Please, Login
Not Available